Month: May 2024

24% Reduction in Kidney Events on Semaglutide; TikTok bans Weight Meds Marketing; Bariatric Surgery Cures Infertility; 50% Discontinue GLP-1s at 1y.

24% Reduction in Kidney Events on Semaglutide; TikTok bans Weight Meds Marketing; Bariatric Surgery Cures Infertility; 50% Discontinue GLP-1s at 1y.

May 26, 2024 No Comments

AT A GLANCE The American Heart Association ‘…highlights the barriers to treatment and improvements needed in translating the science of obesity to patient care.’ Daniel Gilbert at The Washington Post reports on the ban of TikTok star Taylor Huber who is paid to promote weight-loss medications. The New England Journal of Medicine reports a 24% reduction in kidney disease events, or death from kidney-related or cardiovascular

Read More »
‘South Park’ on Obesity; Novo Trial on Alcoholic Liver Disease; Bernie Sanders Blasts Wegovy Prices; Bariatric Surgery Protects Against Breast Cancer.

‘South Park’ on Obesity; Novo Trial on Alcoholic Liver Disease; Bernie Sanders Blasts Wegovy Prices; Bariatric Surgery Protects Against Breast Cancer.

May 19, 2024 No Comments

AT A GLANCE ‘It’s time for some drastic measures to bring down his weight…’ says the doctor in the trailer for South Park: The End of Obesity. STAT on Novo Nordisk to test GLP-1 drugs for people with alcohol-associated liver disease. The Hill on Senate Health Committee Chair Bernie Sanders stating Wegovy could bankrupt US health system. JAMA on bariatric surgery protection against development of breast cancer. STAT on

Read More »
Novo’s-new-Drug-Development-Partnership;-Oprah-on-Making-the-Shift;-No-One-Knows-How-to-Talk-About-Weight-Loss-Anymore;-One-in-Eight-Adults-in-US-have-taken-a-GLP-1-Drug

Novo’s new Drug Development Partnership; Oprah on Making the Shift; No One Knows How to Talk About Weight Loss Anymore; One in Eight Adults in US have taken a GLP-1 Drug.

May 12, 2024 No Comments

AT A GLANCE Reuters states Novo Nordisk ties up with Metaphore from Flagship Pioneering to develop new obesity drugs. Oprah, in collaboration with Weightwatchers CEO Sima Sistani, joined by actress Rebel Wilson, as well as obesity experts this week. I am encouraged to read Jamie Ducharme’s article in TIME this week titled No One Knows How to Talk About Weight Loss Anymore – spot on! Betsy McKay

Read More »
Eli-and-Novo-beat-Q1-Earnings;-Amgen’s-Monthly-Injectable-GLP-1-Candidate;-Ozempic-Babies;-Bariatric-Surgery-Impacts-Kidney-Transplant-Rates

Eli and Novo beat Q1 Earnings; Amgen’s Monthly Injectable GLP-1 Candidate; Ozempic Babies; Bariatric Surgery Impacts Kidney Transplant Rates.

May 5, 2024 No Comments

AT A GLANCE Amgen to focus on MariTide, an monthly injectable monoclonal antibody, rather than AMG 786, its early-stage obesity pill, from STAT News. Elaine Chen at STAT notes Eli Lilly raised its full-year guidance on Tuesday while it reported strong first-quarter sales of Zepbound. The Wall Street Journal reports sales of Wegovy more than doubled in the first quarter. Online pharmacies and slimming clinics are cutting prices

Read More »
Categories
Archives
Scroll to Top
Skip to content